rs121912947
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PS1_ModeratePM2PP3_StrongPP5_Very_Strong
The NM_080680.3(COL11A2):c.3100C>T(p.Arg1034Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,460,674 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in UniProt.
Frequency
Consequence
NM_080680.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL11A2 | NM_080680.3 | c.3100C>T | p.Arg1034Cys | missense_variant | 42/66 | ENST00000341947.7 | NP_542411.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL11A2 | ENST00000341947.7 | c.3100C>T | p.Arg1034Cys | missense_variant | 42/66 | 5 | NM_080680.3 | ENSP00000339915.2 | ||
COL11A2 | ENST00000374708.8 | c.2842C>T | p.Arg948Cys | missense_variant | 40/64 | 5 | ENSP00000363840.4 | |||
COL11A2 | ENST00000477772.1 | n.272+5246C>T | intron_variant | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460674Hom.: 0 Cov.: 38 AF XY: 0.00 AC XY: 0AN XY: 726660
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 18, 2023 | This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 1034 of the COL11A2 protein (p.Arg1034Cys). This missense change has been observed in individual(s) with autosomal dominant deafness (PMID: 10581026, 33105617). It has also been observed to segregate with disease in related individuals. For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt COL11A2 protein function. ClinVar contains an entry for this variant (Variation ID: 17124). This variant is also known as p.Arg549Cys. - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2017 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Dec 20, 2024 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed in large population cohorts (gnomAD); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 15372529, 33105617, 10581026) - |
COL11A2-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 05, 2023 | The COL11A2 c.3100C>T variant is predicted to result in the amino acid substitution p.Arg1034Cys. This variant has been reported to segregate with autosomal dominant nonsyndromic hearing loss in a large family with 24 affected individuals (described as p.Arg549Cys, McGuirt. 1999. PubMed ID: 10581026) and was also reported in a single apparently unrelated individual with nonsyndromic hearing loss (Morgan. 2020. PubMed ID: 33105617). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as pathogenic. - |
Autosomal dominant nonsyndromic hearing loss 13 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 1999 | - - |
Rare genetic deafness Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 15, 2017 | The p.Arg1034Cys variant in COL11A2 has been reported in 3 unrelated individuals with hearing loss and segregated in 25 affected relatives in 2 families with au tosomal dominant nonsyndromic sensorineural hearing loss (McGuirt 1999, LMM data ). It has not been identified in large population studies. Computational predict ion tools and conservation analysis suggest that the variant may impact the prot ein. Variants in COL11A2 have been associated with both dominant and recessive h earing loss that can be either syndromic or nonsyndromic. However, there have be en only 2 families with autosomal dominant nonsyndromic hearing loss with signif icant segregation data in the published literature (McGuirt 1999). In summary, a lthough additional studies are required to fully establish its clinical signific ance, the p.Arg1034Cys variant is likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at